Intermediate Outcomes of Deep Sclerectomy in Juvenile Glaucoma

医学 青光眼 眼压 眼科 回顾性队列研究 视力 青光眼药物治疗 外科
作者
Shaima S. Alharbi,Ibrahim Al Obaida,Ibrahim Al Jadaan,Adi Mohammed Al Owaifeer
出处
期刊:Journal of Glaucoma [Ovid Technologies (Wolters Kluwer)]
卷期号:31 (4): 280-284 被引量:3
标识
DOI:10.1097/ijg.0000000000001978
摘要

In this retrospective study of patients with predominantly severe juvenile open-angle glaucoma, deep sclerectomy (DS) achieved a success rate [defined as intraocular pressure (IOP) between 5 to 18 mm Hg] of 72% at 3 years.The purpose of this study was to evaluate the safety and efficacy of DS in patients with juvenile open-angle glaucoma (JOAG).A retrospective chart review of all JOAG patients that underwent DS with mitomycin C at a tertiary care eye center during the period from May 2014 to May 2019.A total of 50 eyes in 37 patients were included. The mean age at the time of surgery was 27.1±11.3 years and the majority of patients (86%) had a cup-disc ratio of 0.8 to 0.9. The mean duration of follow-up was 26.1±13.4 months (range 12 to 54 mo). Mean IOP was reduced from 26.1±13.4 mm Hg at baseline to 15.2±6.4 mm Hg at the last follow-up visit (P<0.01). Moreover, the mean number of glaucoma medications decreased from 3.8±0.5 at baseline to 0.8±1.2 at the last follow-up visit (P<0.01). The cumulative probabilities of overall success (defined as IOP between 5 and 18 mm Hg) at 12, 24, and 36 months were 94%, 85%, and 72%, respectively. Hypotony occurred in 4 eyes (8%), and in one of these patients, the final visual acuity was >2 lines worse compared with presentation. No other vision-threatening complications were encountered.DS in JOAG was safe and successfully controlled IOP in most patients for 3 years.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
swiftie完成签到,获得积分10
刚刚
最专业发布了新的文献求助10
刚刚
杳鸢应助xanderxue采纳,获得10
刚刚
NZH关闭了NZH文献求助
1秒前
Tioner完成签到,获得积分10
1秒前
1秒前
君士坦丁十二世关注了科研通微信公众号
3秒前
3秒前
3秒前
Luantyi发布了新的文献求助10
5秒前
在水一方应助科研通管家采纳,获得10
5秒前
5秒前
Hello应助科研通管家采纳,获得10
5秒前
研友_VZG7GZ应助务实大船采纳,获得10
5秒前
5秒前
5秒前
pluto应助科研通管家采纳,获得30
5秒前
小二郎应助科研通管家采纳,获得10
5秒前
Tsuki完成签到,获得积分10
5秒前
5秒前
上官若男应助Yy采纳,获得10
5秒前
123发布了新的文献求助10
7秒前
XD小黑发布了新的文献求助10
7秒前
陈陈陈完成签到,获得积分10
7秒前
啊呜完成签到,获得积分10
7秒前
7秒前
17ss完成签到,获得积分10
8秒前
8秒前
yehuitao发布了新的文献求助10
8秒前
FashionBoy应助雾山行采纳,获得10
8秒前
Hammerdai发布了新的文献求助10
8秒前
Morgen发布了新的文献求助10
9秒前
Pjmeng完成签到,获得积分10
9秒前
Captain完成签到 ,获得积分10
9秒前
芋圆完成签到,获得积分10
10秒前
余儿完成签到,获得积分10
11秒前
11秒前
11秒前
无花果应助温婉的勒采纳,获得10
12秒前
12秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 900
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
錢鍾書楊絳親友書札 600
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3296524
求助须知:如何正确求助?哪些是违规求助? 2932367
关于积分的说明 8456236
捐赠科研通 2604886
什么是DOI,文献DOI怎么找? 1422043
科研通“疑难数据库(出版商)”最低求助积分说明 661269
邀请新用户注册赠送积分活动 644326